سيرينيا أقراص
Cerenia (maropitant citrate) Tablets are an oral NK1 receptor antagonist indicated for the prevention of acute vomiting and the prevention of vomiting due to motion sickness in dogs.
الشكل الصيدلاني
Tablet
نوع المنتج
دواء
الشركة المصنعة
الحجم
Blister packs of 4 tablets available in strengths: 16 mg, 24 mg, 60 mg, and 160 mg
| النوع الحيواني | الجرعة | طريقة الإعطاء | المدة |
|---|---|---|---|
| Dog | Acute vomiting: minimum 2 mg/kg PO once daily for up to 5 days. Motion sickness: minimum 8 mg/kg PO once daily for up to 2 consecutive days. | Oral (PO) | Up to 5 days for acute vomiting; up to 2 days for motion sickness |
لا توجد معلومات سحب متاحة.
Prevention of acute vomiting in dogs 2 months of age and older.
Prevention of vomiting caused by motion sickness in dogs 4 months of age and older.
Do not use in dogs with known hypersensitivity to maropitant citrate.
Do not use for motion sickness in puppies younger than 16 weeks of age.
Do not wrap tablet in fatty treats or hot dogs as this may delay absorption and decrease efficacy.
Use with caution in dogs with hepatic dysfunction.
Safety has not been established in breeding, pregnant, or lactating dogs.
Excessive salivation/drooling, drowsiness or lethargy, retching, and diarrhea.
Cerenia Tablets Prescribing Information
نشرةلا توجد أمراض مرتبطة.
لا توجد بيانات
لم تتم إضافة المعلومات بعد.
شركة مصنعة
لا توجد بدائل متاحة.